CELLAGENICS B V has a total of 18 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2010. It filed its patents most often in WIPO (World Intellectual Property Organization), China and EPO (European Patent Office). Its main competitors in its focus markets biotechnology and foods and drinks are RUBICON FORESTS HOLDINGS LTD, DIATECH LTD and BANGLADESH JUTE RES INST.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | China | 3 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | South Africa | 3 | |
#5 | Brazil | 2 | |
#6 | United States | 2 | |
#7 | Israel | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Enzymes | |
#3 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Otte Arie Pieter | 17 |
#2 | Verhees John Antonius | 17 |
#3 | Van Blokland Henricus Johannes Maria | 13 |
#4 | Hoeksema Femke | 11 |
#5 | Siep Michel | 7 |
#6 | Blokland Henricus Johannes Maria Van | 2 |
#7 | Arie Pieter Otte | 1 |
#8 | Van Blockland Henricus Johannes Maria | 1 |
#9 | John Antonius Verhees | 1 |
#10 | Michel Siep | 1 |
Publication | Filing date | Title |
---|---|---|
WO2012030218A1 | Nucleic acid fragments from a ribosomal protein promoter for enhancing gene expression | |
EP2443239A2 | Novel stringent selectable markers |